Filipa Lynce

38PUBLICATIONS
219CO-AUTHORS
Cancer geneticsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|May 25, 2026
Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort studies.

|May 14, 2026
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025.

|Mar 10, 2026
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

Natasha B Hunter, Heather A Parsons, Leslie Cope

|Dec 03, 2025
A Phase Ib Study of Sapacitabine and Olaparib in Patients with BRCA1/2-Mutated Metastatic Breast Cancer.

Filipa Lynce, Noah Graham, Bose S Kochupurakkal

|Sep 30, 2025
Neoadjuvant therapy with eribulin, doxorubicin and cyclophosphamide for patients with HER2-negative inflammatory breast cancer: a phase II study.

Kristina Fanucci, Eren D Yeh, Ruichao Shi

|May 16, 2025
Clinicogenomic Characterization of Inflammatory Breast Cancer.

Nolan Priedigkeit, Beth Harrison, Robert Shue

Pageof 7

Frequent Collaborators

11 joint publications

Sara M Tolaney

7 joint publications

Ilana Schlam

5 joint publications

Claudine Isaacs

5 joint publications

Paolo Tarantino